Chlamydia trachomatis Elispot

Chlamydia trachomatis EliSpot
AONM/ArminLabs

"AONM have checklists that help identify the most likely viral or bacterial infections to test for, based on patient symptoms. Please see https://aonm.org/checklists-for-testing/ or contact AONM at 03331 210305 or email info@aonm.org. We also offer different viral and bacterial panels, and are always happy to advise on testing options."

Please note this test requires a blood draw, please organise a phlebotomist for your patient. A return courier fee of £50 is included in this test price

Description:
This test reflects the current Chlamydia trachomatis activity of chronic and recent Chlamydia trachomatis infections.

Chlamydia trachomatis is an obligate intracellular bacterium, gram negative. This bacterium is responsible for Chlamydia (or chlamydia) urethritis, a sexually transmitted disease that is most common in Latin America and the USA after Papillomavirus (50 times more frequent than gonorrhoea, which is more common than syphilis). Its reservoir is strictly human.

The EliSpot is highly sensitive and can detect even one single Chlamydia trachomatis-reactive T-cell. With detection levels that can be as low as one cell in 100,000, the EliSpot is one of the most sensitive cellular assays available.

Methodology:
Chlamydia trachomatis EliSpot (T-Cell-Spot / IGRA: Interferon-Gamma-Release Assay)

When should I use:
When a recent or chronic case of Chlamydia trachomatis infection is suspected.

Other details:
AONM has checklists that help identify the most likely viral or bacterial infections to test for, based on patient symptoms. Please see https://aonm.org/checklists-for-testing/ or contact AONM at 03331 210305 or email info@aonm.org. We also offer different viral and bacterial panels and are always happy to advise on testing options. The EliSpot can be helpful when monitoring therapies.

The EliSpot should usually become negative about 4 to 8 weeks after completion of an effective therapy.

The symptoms of Chlamydia trachomatis infection can include:

• Discharge: Abnormal discharge from the genitals.
• Painful Urination: Burning sensation during urination.
• Genital Itching or Irritation: Itching or discomfort in the genital area.
• Abdominal Pain: Lower abdominal pain or discomfort.
• Bleeding: Abnormal bleeding between periods or after intercourse (in females).
• Pain During Intercourse: Painful sexual intercourse (in females).

Chlamydia trachomatis infections may be asymptomatic, particularly in females, but can lead to serious complications if untreated.

Biomarkers

Chlamydia trachomatis EliSpot

Specification

Specimen Type:

3 x CPDA tube

Vitality of T-cells for LTT: Up to 3 days

Phlebotomy Type:

Blood draw at home or in a clinical setting